Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 71.2158.3639.8458.8548.37

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 71.21 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202571.21
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2025 71.21
22.02
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹21,850.3 Cr -2.9% -1.2% 26.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr -0.1% 4.7% 6.2% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.7% 2.5% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -1.1% 7.6% 45.4% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr -0.4% 6.3% 14.7% Stock Analytics
CIPLA ₹106,768.0 Cr -2.3% 0.3% -8.9% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-2.9%

-1.2%

26.2%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses